SenzaGen AB
SENZA
Rank in Stocks
#27228
SenzaGen AB specializes in pioneering, conducting, and commercializing... SenzaGen AB specializes in pioneering, conducting, and commercializing animal-free methods to evaluate the allergic potential of various substances. Their product portfolio encompasses several in vitro tests: GARDskin identifies potential chemical skin sensitizers; GARDpotency, an enhancement to GARDskin, categorizes their strength; GARDskin Dose-response delivers precise quantitative assessment of skin sensitizing potency; and GARDair detects chemical respiratory sensitizers. They also offer GARDskin medical device for assessing skin sensitization caused by medical equipment and solid materials. Furthermore, the company provides services for irritation and corrosion analysis. SenzaGen distributes its solutions through a network of licensed partners and distributors. The firm also collaborates with the Research Institute for Fragrance Materials to develop novel photosensitization tests. Founded in 2010, the company's headquarters are located in Lund, Sweden.
Share Price
$0.49482678
Last synced: 2026-11-09
Market Cap
$16.09M
Change (1 day)
-1.12%
Change (1 year)
-24.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SenzaGen AB (SENZA)
Category
Healthcare
Operating Margin for SenzaGen AB (SENZA)
Operating Margin as of November 2026 TTM: -19.45%
According to SenzaGen AB's latest financial reports, its current operating margin (TTM) is -19.45%. At the end of 2025 the company had an operating margin of -19.83%.
Operating Margin history for SenzaGen AB from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -19.45% | -1.92% |
| 2025 | -19.83% | -39.62% |
| 2024 | -32.84% | 11.10% |
| 2023 | -29.56% | -38.85% |
| 2022 | -48.34% | -76.36% |
| 2021 | -204.47% | -39.95% |
| 2020 | -340.51% | -75.54% |
| 2019 | -1,392.33% | 34.12% |
| 2018 | -1,038.11% | -27.92% |
| 2017 | -1,440.24% | -36.73% |
| 2016 | -2,276.31% | 714.86% |
| 2015 | -279.35% | -1,145.47% |
| 2014 | 26.72% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -100.92% |
US
|
|
| 20.38% | -101.05% |
US
|
|
| 43.02% | -102.21% |
CN
|
|
| 32.03% | -101.65% |
US
|
|
| 22.23% | -101.14% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SenzaGen AB's operating margin
What is SenzaGen AB's operating margin?
SenzaGen AB's operating margin is -19.45%, as of Nov 2026.
What was SenzaGen AB's operating margin in 2025?
In 2025, SenzaGen AB's operating margin was -19.83%, compared with -32.84% in 2024.
How has SenzaGen AB's operating margin changed since 2020?
From 2020 to 2025, SenzaGen AB's operating margin was highest in 2025 (-19.83%) and lowest in 2020 (-340.51%).
How does SenzaGen AB's operating margin compare with similar companies?
SenzaGen AB's operating margin (-19.45%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.